Innovations in Proteomics: Insights from Chris Lock at ASMS 2025
July 11, 2025 - 05:58
At the recent ASMS 2025 conference, Chris Lock from SCIEX shared valuable insights into the advancements in proteomics technology. He highlighted how recent innovations are significantly enhancing the sensitivity and identification capabilities of proteomics workflows. These improvements are crucial for researchers aiming to detect a wider array of proteins with greater precision than ever before.
Lock emphasized that the evolution of mass spectrometry and other analytical techniques is paving the way for breakthroughs in various fields, including drug discovery, disease research, and personalized medicine. The ability to identify low-abundance proteins and accurately characterize complex biological samples is transforming how scientists approach their research.
As proteomics continues to advance, the integration of cutting-edge technologies promises to unlock new opportunities for understanding biological processes and developing targeted therapies. The discussions at ASMS 2025 underscored the importance of these innovations in pushing the boundaries of what is possible in proteomics research.
MORE NEWS
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...